Literature DB >> 8941214

The role of vacuolar H(+)-ATPase in the control of intragranular pH and exocytosis in eosinophils.

K Kurashima1, M Numata, A Yachie, Y Sai, N Ishizaka, M Fujimura, T Matsuda, S Ohkuma.   

Abstract

The presence of vacuolar H(+)-ATPase (V-ATPase) on exocytotic granules in eosinophils and the role of this enzyme in exocytosis were explored in this study. Antibody against 116-kd subunit of V-ATPase positively stained eosinophil granules in immunofluorescence analysis. When eosinophil lysate was extracted immunomagnetically with the same antibody, the extracted fraction contained a considerable amount of eosinophil peroxidase, a marker of eosinophil-specific granules, which indicates that V-ATPase was present on the membranes of eosinophil exsosomal granules. The pH of the eosinophil granules, measured fluorometrically with acridine orange as a delta pH-sensitive dye, was estimated to be 5.1. The acidity of the eosinophil granules was perturbed by bafilomycin A1, a potent selective inhibitor of V-ATPase, which indicates that the low pH of these granules is maintained by V-ATPase activity. BafilomycinA1 and NH4Cl, both of which raise the intragranular pH to neutral, inhibited the eosinophil peroxidase exocytosis induced by platelet-activating factor. These agents did not, however, affect the changes in cytosolic free calcium concentration [Ca2+]i induced by platelet-activating factor. These observations suggest that bafilomycin A1 inhibited a delta pH-requiring step in eosinophil exocytosis that was preceded by the [Ca2+]i transient in the signal transduction pathway, and, hence, the findings suggest the pivotal role of V-ATPase in maintaining intragranular pH and its function of eosinophil exosomal granules.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8941214

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  9 in total

1.  Eosinophil granules function extracellularly as receptor-mediated secretory organelles.

Authors:  Josiane S Neves; Sandra A C Perez; Lisa A Spencer; Rossana C N Melo; Lauren Reynolds; Ionita Ghiran; Salahaddin Mahmudi-Azer; Solomon O Odemuyiwa; Ann M Dvorak; Redwan Moqbel; Peter F Weller
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-18       Impact factor: 11.205

2.  Autophagy Protects against Eosinophil Cytolysis and Release of DNA.

Authors:  Stephane Esnault; Paul S Fichtinger; Karina T Barretto; Frances J Fogerty; Ksenija Bernau; Deane F Mosher; Sameer K Mathur; Nathan Sandbo; Nizar N Jarjour
Journal:  Cells       Date:  2022-06-02       Impact factor: 7.666

3.  Eosinophilic esophagitis: interactions with gastroesophageal reflux disease.

Authors:  Edaire Cheng; Rhonda F Souza; Stuart Jon Spechler
Journal:  Gastroenterol Clin North Am       Date:  2014-03-24       Impact factor: 3.806

Review 4.  Proton pump inhibitors for eosinophilic oesophagitis.

Authors:  Edaire Cheng
Journal:  Curr Opin Gastroenterol       Date:  2013-07       Impact factor: 3.287

5.  Post-translational tyrosine nitration of eosinophil granule toxins mediated by eosinophil peroxidase.

Authors:  Martina Ulrich; Alina Petre; Nikolay Youhnovski; Franziska Prömm; Markus Schirle; Michael Schumm; Ralph S Pero; Alfred Doyle; James Checkel; Hirohito Kita; Nethaji Thiyagarajan; K Ravi Acharya; Peter Schmid-Grendelmeier; Hans-Uwe Simon; Heinz Schwarz; Masato Tsutsui; Hiroaki Shimokawa; Gabriel Bellon; James J Lee; Michael Przybylski; Gerd Döring
Journal:  J Biol Chem       Date:  2008-08-11       Impact factor: 5.157

Review 6.  Functional extracellular eosinophil granules: novel implications in eosinophil immunobiology.

Authors:  Josiane S Neves; Peter F Weller
Journal:  Curr Opin Immunol       Date:  2009-08-24       Impact factor: 7.486

Review 7.  Airway acidification: interactions with nitrogen oxides and airway inflammation.

Authors:  John Hunt
Journal:  Curr Allergy Asthma Rep       Date:  2006-02       Impact factor: 4.919

Review 8.  Analysing the eosinophil cationic protein--a clue to the function of the eosinophil granulocyte.

Authors:  Jonas Bystrom; Kawa Amin; David Bishop-Bailey
Journal:  Respir Res       Date:  2011-01-14

9.  Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells.

Authors:  Xi Zhang; Edaire Cheng; Xiaofang Huo; Chunhua Yu; Qiuyang Zhang; Thai H Pham; David H Wang; Stuart J Spechler; Rhonda F Souza
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.